Vida Ventures
Vida Ventures focuses on investments in the life sciences industry.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Vida Ventures Information
Geographic Data
Address: 40 Broad Street
City: Boston
State: MA
Zip: 02109
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$2B
Social
Metrics
2,102,652Website Global Rank
9,490Website Monthly Traffic
Twitter Followers
Description
Vida Ventures focuses on investments in the life sciences industry.
Contact Phone:
+18572549500
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2021 | Volastra Therapeutics | Seed | 32M |
| 12/2020 | Innoskel | Series A | 0 |
| 8/2017 | Homology Medicines | Series B | 83.5M |
| 7/2018 | Sutro Biopharma | Series E | 0 |
| 12/2020 | Locanabio | Series B | 0 |
| 10/2020 | LianBio | Series A | 0 |
| 10/2020 | A2 Biotherapeutics | Series B | 71.5M |
| 10/2019 | Remedico | Seed Round | 500k |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 3/2022 | Affini-T Therapeutics | Venture Round | 0 |
| 3/2020 | ReCode Therapeutics | Series A | 0 |
| 1/2021 | IconOVir Bio | Series A | 0 |
| 4/2021 | Tectonic Therapeutic | Series A | 80M |
| 6/2018 | Kronos Bio | Seed Round | 0 |
| 11/2019 | A2 Biotherapeutics | Series A | 57M |
| 2/2019 | Kadiant | Seed Round | - |
| 7/2019 | Kronos Bio | Series A | 105M |
| 4/2018 | Allogene | Series A | 0 |
| 9/2022 | Capstan Therapeutics | Series A | 102M |
| 2/2019 | Peloton Therapeutics | Series E | 0 |
| 2/2019 | Oyster Point Pharmaceuticals | Series B | 0 |
| 10/2020 | Scorpion Therapeutics | Series A | 108M |
| 11/2021 | Capstan Therapeutics | Seed Round | 63M |
| 8/2020 | Kronos Bio | Private Equity Round | 155M |
| 3/2021 | Aktis Oncology | Series A | 72M |
| 8/2022 | Aktis Oncology | Series A | 0 |
| 10/2021 | ReCode Therapeutics | Series B | 0 |
| 10/2021 | Protego Biopharma | Series A | 0 |
| 1/2020 | PACT Pharma | Series C | 0 |
| 12/2017 | Pionyr Immunotherapeutics | Series B | 0 |
| 1/2022 | Kyverna Therapeutics | Series B | 0 |
| 1/2020 | Kyverna Therapeutics | Series A | 25M |
| 7/2020 | Praxis Precision Medicines | Series C | 0 |
| 8/2020 | Kinnate Biopharma | Series C | 98M |
| 9/2020 | Neogene Therapeutics | Series A | 110M |
| 2/2021 | Centessa Pharmaceuticals | Series A | 250M |
| 10/2021 | Quanta Therapeutics | Series C | 60M |
| 1/2021 | Scorpion Therapeutics | Series B | 162M |
| 12/2019 | Kinnate Biopharma | Series B | 74.5M |
| 1/2022 | Alterome Therapeutics | Series A | 0 |
| 11/2022 | Alterome Therapeutics | Series A | 0 |
| 3/2023 | Volastra Therapeutics | Series A | 0 |
| 1/2019 | A2 Biotherapeutics | Seed Round | - |
| 8/2020 | Dyne Therapeutics | Series B | 115M |
| 4/2019 | Asklepios BioPharmaceutical | Private Equity Round | 235M |
| 3/2022 | Affini-T Therapeutics | Venture Round | 0 |
| 1/2022 | Kyverna Therapeutics | Series B | 0 |
| 1/2022 | Alterome Therapeutics | Series A | 0 |
| 10/2021 | Quanta Therapeutics | Series C | 0 |
| 10/2021 | ReCode Therapeutics | Series B | 0 |
| 10/2021 | Protego Biopharma | Series A | 0 |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 4/2021 | Tectonic Therapeutic | Series A | 0 |
| 4/2021 | Volastra Therapeutics | Seed Round | 0 |
| 3/2021 | Aktis Oncology | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2021 | Investment Fund | $825M | 4/2018 | Investment Fund | $295M | 7/2019 | Investment Fund | $600M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
